AU522556B2 - Antihemophilic factor preparation - Google Patents

Antihemophilic factor preparation

Info

Publication number
AU522556B2
AU522556B2 AU52231/79A AU5223179A AU522556B2 AU 522556 B2 AU522556 B2 AU 522556B2 AU 52231/79 A AU52231/79 A AU 52231/79A AU 5223179 A AU5223179 A AU 5223179A AU 522556 B2 AU522556 B2 AU 522556B2
Authority
AU
Australia
Prior art keywords
antihemophilic factor
factor preparation
preparation
antihemophilic
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU52231/79A
Other languages
English (en)
Other versions
AU5223179A (en
Inventor
Jorgen Frederik Hansen
Jorgen Vikelsoe Jensen
Mirella Ezban Rasmussen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nordisk Insulinlaboratorium
Original Assignee
Nordisk Insulinlaboratorium
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordisk Insulinlaboratorium filed Critical Nordisk Insulinlaboratorium
Publication of AU5223179A publication Critical patent/AU5223179A/en
Application granted granted Critical
Publication of AU522556B2 publication Critical patent/AU522556B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01R—ELECTRICALLY-CONDUCTIVE CONNECTIONS; STRUCTURAL ASSOCIATIONS OF A PLURALITY OF MUTUALLY-INSULATED ELECTRICAL CONNECTING ELEMENTS; COUPLING DEVICES; CURRENT COLLECTORS
    • H01R13/00—Details of coupling devices of the kinds covered by groups H01R12/70 or H01R24/00 - H01R33/00
    • H01R13/46—Bases; Cases
    • H01R13/52—Dustproof, splashproof, drip-proof, waterproof, or flameproof cases
    • H01R13/5219—Sealing means between coupling parts, e.g. interfacial seal
    • H01R13/5221—Sealing means between coupling parts, e.g. interfacial seal having cable sealing means
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AU52231/79A 1978-11-01 1979-10-26 Antihemophilic factor preparation Ceased AU522556B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK487578 1978-11-01
DK487578 1978-11-01

Publications (2)

Publication Number Publication Date
AU5223179A AU5223179A (en) 1980-05-08
AU522556B2 true AU522556B2 (en) 1982-06-10

Family

ID=8137444

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52231/79A Ceased AU522556B2 (en) 1978-11-01 1979-10-26 Antihemophilic factor preparation

Country Status (20)

Country Link
US (1) US4251437A (fi)
JP (1) JPS5585523A (fi)
AR (1) AR217576A1 (fi)
AT (1) AT369652B (fi)
AU (1) AU522556B2 (fi)
BE (1) BE879733A (fi)
CA (1) CA1119094A (fi)
DD (1) DD146892A5 (fi)
DE (1) DE2943512A1 (fi)
ES (1) ES485550A1 (fi)
FI (1) FI63521C (fi)
FR (1) FR2440193A1 (fi)
GB (1) GB2034327B (fi)
HU (1) HU180898B (fi)
IL (1) IL58541A (fi)
IT (1) IT1162791B (fi)
NL (1) NL7907984A (fi)
NO (1) NO793501L (fi)
OA (1) OA06368A (fi)
SE (1) SE7909026L (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3033932C2 (de) * 1980-09-10 1984-05-24 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Kaltsterilisation von Blutgerinnungsfaktor VIII enthaltenden Präparaten
US4620908A (en) * 1983-10-03 1986-11-04 Biocell Laboratories, Inc. Method for destroying microbial contamination in protein materials
US4975246A (en) * 1985-09-30 1990-12-04 Charm Stanley E High temperature, short time heating system and method of heating heat-sensitive material
US4839142A (en) * 1985-09-30 1989-06-13 Charm Stanley E High temperature, short time heating system and method of sterilizing or pasteurizing heat sensitive biological fluids
FR2634381B1 (fr) * 1988-07-25 1990-09-07 Morez Jean Bernard Procede pour la fabrication de medicaments homeopathiques en une seule operation quelque soit la dilution choisie
WO1991010450A1 (fr) * 1990-01-11 1991-07-25 Morez Jean Bernard Procede pour la fabrication homeopatiques en une seule operation quelque soit la dilution choisie
US6187572B1 (en) 1990-04-16 2001-02-13 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
US5418130A (en) * 1990-04-16 1995-05-23 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
US5644032A (en) * 1990-08-06 1997-07-01 Fibrin Corporation Process for producing fibrinogen concentrates
DE4308360C1 (de) * 1993-03-16 1994-10-27 Transmed Medtech Gmbh Aufwärm- und Auftaugerät
US5362442A (en) * 1993-07-22 1994-11-08 2920913 Canada Inc. Method for sterilizing products with gamma radiation
US20040067157A1 (en) * 1993-07-22 2004-04-08 Clearant, Inc. Methods for sterilizing biological materials
US5616268A (en) * 1994-07-07 1997-04-01 Microwave Medical Systems Microwave blood thawing with feedback control
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders
US20040086420A1 (en) * 2000-03-23 2004-05-06 Macphee Martin J. Methods for sterilizing serum or plasma
US6682695B2 (en) * 2001-03-23 2004-01-27 Clearant, Inc. Methods for sterilizing biological materials by multiple rates
US6696060B2 (en) 2001-06-14 2004-02-24 Clearant, Inc. Methods for sterilizing preparations of monoclonal immunoglobulins
US20030031584A1 (en) * 2001-08-10 2003-02-13 Wilson Burgess Methods for sterilizing biological materials using dipeptide stabilizers
US6946098B2 (en) 2001-08-10 2005-09-20 Clearant, Inc. Methods for sterilizing biological materials
US7252799B2 (en) 2001-08-31 2007-08-07 Clearant, Inc. Methods for sterilizing preparations containing albumin
US6749851B2 (en) 2001-08-31 2004-06-15 Clearant, Inc. Methods for sterilizing preparations of digestive enzymes
US20030095890A1 (en) * 2001-09-24 2003-05-22 Shirley Miekka Methods for sterilizing biological materials containing non-aqueous solvents
US20110091353A1 (en) * 2001-09-24 2011-04-21 Wilson Burgess Methods for Sterilizing Tissue
US6783968B2 (en) 2001-09-24 2004-08-31 Clearant, Inc. Methods for sterilizing preparations of glycosidases
US20030185702A1 (en) * 2002-02-01 2003-10-02 Wilson Burgess Methods for sterilizing tissue
US20030124023A1 (en) * 2001-12-21 2003-07-03 Wilson Burgess Method of sterilizing heart valves
US20030180181A1 (en) * 2002-02-01 2003-09-25 Teri Greib Methods for sterilizing tissue
US20040013562A1 (en) * 2002-07-18 2004-01-22 Wilson Burgess Methods for sterilizing milk.
US6908591B2 (en) * 2002-07-18 2005-06-21 Clearant, Inc. Methods for sterilizing biological materials by irradiation over a temperature gradient
US20060226086A1 (en) * 2005-04-08 2006-10-12 Robinson Thomas C Centrifuge for blood processing systems
DE202010004830U1 (de) 2010-04-10 2010-07-29 Pelster, Michael, Dipl.-Ing. Vorrichtung zum Auftauen und/oder Erwärmen von sich in einem Behältnis befindlichen medizinischen Gut
US9173248B2 (en) * 2011-03-14 2015-10-27 Products Support, Inc. Thawing oven

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2867567A (en) * 1955-01-21 1959-01-06 Nat Res Dev Process of preparing anti-haemophilic globulin
US3492212A (en) * 1966-12-01 1970-01-27 Hoffmann La Roche Ultrasonic treatment of protein materials
US3652530A (en) * 1967-08-28 1972-03-28 American Nat Red Cross Antihemophilic factor prepared from blood plasma using polyethylene glycol
US3645849A (en) * 1969-04-17 1972-02-29 Gray Ind Inc Stability of enzymes
FR2363577A1 (fr) * 1976-09-03 1978-03-31 Recherches Hematologiques Procede simplifie pour preparer avec un rendement eleve du concentre de facteur antihemophilique pur

Also Published As

Publication number Publication date
NO793501L (no) 1980-05-05
JPS5585523A (en) 1980-06-27
BE879733A (fr) 1980-04-30
OA06368A (fr) 1981-07-31
DD146892A5 (de) 1981-03-11
AT369652B (de) 1983-01-25
ES485550A1 (es) 1980-07-01
HU180898B (en) 1983-05-30
SE7909026L (sv) 1980-05-02
IL58541A0 (en) 1980-01-31
ATA703979A (de) 1982-06-15
DE2943512A1 (de) 1980-05-14
CA1119094A (en) 1982-03-02
GB2034327A (en) 1980-06-04
US4251437A (en) 1981-02-17
AU5223179A (en) 1980-05-08
NL7907984A (nl) 1980-05-06
FI793389A (fi) 1980-05-02
IL58541A (en) 1982-02-28
GB2034327B (en) 1982-11-17
FI63521B (fi) 1983-03-31
IT1162791B (it) 1987-04-01
IT7926925A0 (it) 1979-10-30
FR2440193A1 (fr) 1980-05-30
FI63521C (fi) 1983-07-11
AR217576A1 (es) 1980-03-31
FR2440193B1 (fi) 1983-04-29

Similar Documents

Publication Publication Date Title
AU522556B2 (en) Antihemophilic factor preparation
AU532651B2 (en) Chair
AU4782679A (en) Oxygenerator
AU4569779A (en) 4-aza-17-substituted-5a-androstan-3-ones
AU1328683A (en) O-alkoxycarbonyl benzenesulfonylisocyanates
AU4583279A (en) Cycloalkyltriazoles
AU4876779A (en) Oxybenzylidiene-bornanones
AU4529679A (en) N-heterocyclyl-4-piperidinamines
AU4655479A (en) Ear-plugs
AU4825779A (en) Benzofuranyl-piperidines
AU4398379A (en) 9-amino-dibenzopyrans
AU4666779A (en) Azolopyrimidinones
AU4406379A (en) 1-aryloxy-3-hitratoalkylamino-2-propanols
AU4530579A (en) Plansifters
AU4754479A (en) Carbamimido thiaotes
AU4642179A (en) 4-quinolinylaminobenzoylpiperidines
AU4506179A (en) Nitrodiarylamines
AU4571479A (en) 2-aminopyrimidones
AU4524379A (en) N-oxacyclic-alkylpiperidyl-diazacompounds
AU4830279A (en) Indolealylamines
AU4814679A (en) Rid-mowse
AU4946279A (en) Imidazoquinoxalines
AU4398479A (en) N-azolylalkyl-halogenoacetanilides
AU4507279A (en) Phenoxyalkylamines
AU4519079A (en) Dilignols